Central nervous system

Apr 05, 2022

Precigen’s PRGN-3006; Yescarta Approved as a First CAR T-cell Therapy for R/R LBCL; Biogen & Ionis’ BIIB078; Nobelpharma’s HYFTOR (sirolimus topical gel) 0.2%; Cerevance Parkinson’s Drug; Sanofi & Regeneron’s Dupixent; Clovis’s Rubraca for Ovarian Cancer; Immunocore Eye Cancer Cell Therapy Approval

Jan 25, 2022

Merck’s Gefapixant; Pfizer’s Somatrogon; Gilead’s Viklury; AbbVie’s Skyrizi; Gilead’s Zydelig Approvals; Lantern’s LP-184; Polpharma to Acquire Advent

Jan 14, 2015

DelveInsight’s Gene Therapy Reports: Launched

Jan 07, 2015

Gene Therapy’s Emergence: The “New” approach for Huntington’s disease

Jan 06, 2015

Are you ready to embrace Gene Therapy?

Dec 20, 2014

DelveInsight’s Central Nervous System Disorders based Gene Therapy Reports

Dec 17, 2014

Break the Gene Therapy Barrier with DelveInsight’s Gene Therapy Reports

Dec 05, 2014

Gene Therapy Market

Newsletter/Whitepaper